Heinrich Schlums

Title: Heinrich Schlums: Innovator in Adaptive Natural Killer Cell Research

Introduction

Heinrich Schlums is a prominent inventor based in Stockholm, Sweden. He has made significant contributions to the field of immunology, particularly in the development of adaptive Natural Killer (NK) cells. With a total of 2 patents, his work focuses on innovative methods for treating viral infections and tumors.

Latest Patents

Schlums' latest patents include groundbreaking research on NK cells exhibiting an adaptive phenotype. This disclosure describes an adaptive NK cell, an isolated population of adaptive NK cells, and a composition that includes these adaptive NK cells. The methods outlined in his patents detail the production, preparation, and application of these adaptive NK cells, which hold promise for treating various viral infections and tumors.

Career Highlights

Heinrich Schlums is affiliated with the Regents of the University of Minnesota, where he continues to advance his research in the field of immunology. His work has garnered attention for its potential impact on therapeutic strategies against challenging health issues.

Collaborations

Some of his notable coworkers include Jeffrey S. Miller and Frank Cichocki, who have collaborated with Schlums on various research projects. Their combined expertise contributes to the innovative approaches being developed in the realm of adaptive NK cell research.

Conclusion

Heinrich Schlums stands out as a key figure in the advancement of adaptive NK cell technology. His patents and research efforts are paving the way for new treatment options in immunotherapy.